Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2021 | Vascular-targeted photodynamic therapy

Lucas Nogueira, MD, Memorial Sloan-Kettering Cancer Center, New York, NY, provides an overview of photodynamic therapy and the more recently developed vascular-targeted photodynamic therapy (VTP), a technique being studied for the localized treatment of a number of tumor types, including prostate cancer and upper tract urothelial carcinoma (UTUC). VTP incorporating the intravascular photosensitizing agent padeliporfin (WTS11), which results in the reactive oxygen species (ROS)-mediated disruption of tumor vasculature upon activation by light, has demonstrated preclinical safety and anti-tumor activity. This interview took place during the 2021 Genitourinary Cancers Symposium.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.